Amphetamine clinical trials
Also written Adzenys XR-ODT.
How each study uses Amphetamine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Amphetamine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 19 Jan 1960 · ADDERALL 5 · NDA 011522 (FDA, Drugs@FDA; in a combination)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
15 studies that test it; most in 2018 (3)
| Year | Studies |
|---|---|
| 2004 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 2 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 8 · Other 7
Tris Pharma, Inc. (3) · Arbor Pharmaceuticals, Inc. (2) · Shire (1) · Neurocrine Biosciences (1) · Yale University (1) · University Hospital, Basel, Switzerland (1) · Emory University (1) · Virginia Commonwealth University (1)
Often tested with
Tested in the same studies.
Guanfacine (1) · TAK-041 (1) · Lysergic Acid Diethylamide (1) · N-Methyl-3,4-methylenedioxyamphetamine (1) · Carbidopa, levodopa drug combination (1) · Methylphenidate (1) · Caffeine (1) · Dextroamphetamine (1)
Related medicines
As reviewed, each with the page that says it.
- One of Stimulants source
- Dextroamphetamine is one of its enantiomers, counted on its own page source
Studies
Open first, then newest update. How each study uses Amphetamine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 15
- A Trial of Dyanavel XR in Treating Co-occurring Fatigue Symptoms in Adults With Attention Deficit Hyperactivity Disorder (ADHD).RecruitingPhase 4Rochester Center for Behavioral MedicineNCT06248229Written as Dyanavel XR
- ADZENYS XR-ODT™ in Children (4 to <6 Years) Diagnosed With Attention-deficit/Hyperactivity DisorderWithdrawnPhase 4Aytu BioPharma, Inc.NCT07169162Written as ADZENYS XR-ODT
- Adult Attention Deficit Hyperactivity Disorder (ADHD) Study With Amphetamine SulfateCompletedPhase 3Arbor Pharmaceuticals, Inc.NCT03659929Written as Amphetamine Sulfate
- Impact of Combined Medication and Behavioral Treatment for ASD & ADHDTerminatedPhase 2Duke UniversityNCT03242772Written as Amphetamine
- Amphetamine Extended Release Tablets and Driving Performance in Subjects With Attention Deficit/Hyperactivity Disorder (ADHD)CompletedPhase 2Tris Pharma, Inc.NCT04027361Written as Amphetamine Extended Release (ER) Tablet 20 mg
- Safety and Tolerability of SPD503 and Psychostimulants in Children and Adolescents Aged 6-17 With Attention-Deficit/Hyperactivity Disorder (ADHD)CompletedPhase 2ShireNCT00151996Written as Amphetamine + SPD503
- A Single-Dose Positron Emission Tomography (PET) Study to Determine the Effect of TAK-041 on Amphetamine-Induced Dopamine Release in the Central Nervous System (CNS)CompletedPhase 1Neurocrine BiosciencesNCT02959892Written as Amphetamine
- Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom SettingCompletedPhase 4Arbor Pharmaceuticals, Inc.NCT01986062Written as AR11
- Test-retest Reproducibility of [11C]PHNO PET Using the Constant Infusion ParadigmCompletedNot applicableYale UniversityNCT01699607Written as Amphetamine
- Dyanavel® XR Extended-Release Oral Suspension in the Treatment of Children With ADHD: A Laboratory School StudyCompletedPhase 3Tris Pharma, Inc.NCT03088267Written as amphetamine extended-release oral suspension, 2.5 mg/mL
- Pharmacokinetic Study of DYANAVEL XR (Amphetamine) Extended-release Oral Suspension, in Children Aged 4 to 5 YearsCompletedPhase 4Tris Pharma, Inc.NCT03610464Written as Amphetamine Extended Release Suspension [Dyanavel]
- Role of Dopamine, Serotonin and 5-HT2A Receptors in Emotion ProcessingCompletedEarly Phase 1University Hospital, Basel, SwitzerlandNCT03019822Written as Amphetamine
- Neurobiological Principles Applied to the Rehabilitation of Stroke PatientsCompletedNot applicableEmory UniversityNCT00715520Written as Amphetamine Sulfate
- Stimulant Enhancement of Well-Being Therapy for DepressionTerminatedNot applicableMassachusetts General HospitalNCT01478113Written as Amphetamine/dextroamphetamine
- Caffeine and CocaineCompletedPhase 1/2Virginia Commonwealth UniversityNCT00733993Written as Amphetamine
Given beside what is tested · 1 — Amphetamine is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with Amphetamine
Codes
What other systems call Amphetamine · ClinicalTrials.gg INT006962
- MeSH (NLM) D000661AmphetamineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) CK833KGX7EAMPHETAMINEConfirmed FDA, NLM, Wikidata
- RxNorm 725Confirmed FDA, Wikidata
- Wikidata Q179452DL-amphetamineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C62006AmphetamineOne source FDA
- DrugBank DB00182One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000661 | Amphetamine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | CK833KGX7E | AMPHETAMINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 725 | — | Confirmed FDA, Wikidata |
| Wikidata | Q179452 | DL-amphetamine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C62006 | Amphetamine | One source FDA |
| DrugBank | DB00182 | — | One source Wikidata |
Also registered as amphetamine sulfate (UNII 6DPV8NK46S · RxNorm 81952).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.